{"uri":"protocols-for-a-systematic-review-and-network-meta-iijcccn","version_id":"1","protocol_name":"Protocols for a systematic review and network meta-analysis of antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention","protocol_name_html":"Protocols for a systematic review and network meta-analysis of antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention","is_prepublished":"0","can_edit":"0","parent_id":"6430","api_version":"1","is_new_mode":"0","last_modified":"1522131061","type_id":"1","link":"https:\/\/doi.org\/10.1371\/journal.pone.0186449","fork_id":"","public_fork_note":null,"number_of_steps":"8","has_versions":"1","first_published_date":"1497885647","publish_date":"2017-10-13 18:07:04","documents":null,"have_protocol_in_step":"0","is_protocol_in_step":"0","vendor_name":"Contributed by users","vendor_link":"https:\/\/www.protocols.io","vendor_logo":"\/img\/vendors\/1.png","mod_mins":"-45","mod_secs":"1","description":"<p><strong>Objective:<\/strong>\u00a0To evaluate the comparative efficacy and safety of antiplatelet agents, vitamin K antagonist (VKA) and non-VKA oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI).<\/p>\n<p><strong>Methods:<\/strong> PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials will be\u00a0searched to identify clinical trials comparing antiplatelet drugs with VKA and NOACs or their combination in AF patients undergoing PCI with a mean\/median follow-up of at least 12 months. A network meta-analysis will\u00a0be\u00a0conducted to directly and indirectly compare the efficacy and safety of competitive antithrombotic regimens with a Bayesian random-effects model.<\/p>","is_bookmarked":"0","can_reassign":"1","before_start":null,"has_guidelines":"0","materials":[],"warning":null,"version_class":"6430","public":"1","is_owner":"1","is_original_owner":"1","created_on":"1497881142","protocol_affiliation":"1Department of Cardiology, Huai\u2019an First People\u2019s Hospital, Nanjing Medical University, Huai\u2019an, Jiangsu, People\u2019s Republic of China.  2Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, People\u2019s Republic of China.","affiliation":null,"doi":"dx.doi.org\/10.17504\/protocols.io.iijcccn","doi_status":"2","changed_fork_steps":null,"profile_url":"x20354x2x2","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","profile_image":"\/img\/avatars\/007.png","full_name":"Xiaoxuan Gong","created_by":"Xiaoxuan Gong","private_link":"7C7B65489AB3038C97F830A16EB09EF5","original_img":"1","username":"xiaoxuan-gong","is_retracted":"0","retraction_reason":null,"plos_id":"10.1371\/journal.pone.0186449","manuscript_citation":"Gong X,  Tang S,  Li J,  Zhang X,  Tian X,  Ma S (2017) Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis. PLoS ONE  12(10): e0186449. doi: <a target=\"_blank\" href=\"https:\/\/dx.doi.org\/10.1371\/journal.pone.0186449\">10.1371\/journal.pone.0186449<\/a> ","journal_name":"PLOS One","is_donations_disabled":"0","is_donations_disabled_by_user":"9","item_record_id":250712,"fork_info":[],"compare_forks":[],"protocols":[],"groups":[],"number_of_shared_runs":[],"ownership_history":[],"keywords":"","transfer_to_user":[],"sub_transfer":false,"is_transfer_pending":false,"number_of_bookmarks":"0","collections":[],"tags":[],"archived":0,"sub_authors":[],"sub_protocols_number":0,"can_edit_shared":0,"shared_runs":[],"is_shared_run":0,"is_shared":1,"banner":null,"contact_badges":[{"badge_id":"2","badge_image":"\/img\/badges\/bronze.svg","badge_description":"Author!"},{"badge_id":"5","badge_image":"\/img\/badges\/earlyadopter.svg","badge_description":"Early adopter"}],"number_of_comments":0,"is_locked":0,"is_locked_by":false,"authors":"Xiaoxuan Gong1*, Shaowen Tang2, Jiangjin Li1, Xiwen Zhang1, Xiaoyi Tian1, Shuren Ma1","authors_list":[{"name":"Xiaoxuan Gong1*","affiliation":"1Department of Cardiology, Huai\u2019an First People\u2019s Hospital, Nanjing Medical University, Huai\u2019an, Jiangsu, People\u2019s Republic of China.  2Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, People\u2019s Republic of China.","username":null,"profile_image":null},{"name":" Shaowen Tang2","affiliation":"1Department of Cardiology, Huai\u2019an First People\u2019s Hospital, Nanjing Medical University, Huai\u2019an, Jiangsu, People\u2019s Republic of China.  2Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, People\u2019s Republic of China.","username":null,"profile_image":null},{"name":" Jiangjin Li1","affiliation":"1Department of Cardiology, Huai\u2019an First People\u2019s Hospital, Nanjing Medical University, Huai\u2019an, Jiangsu, People\u2019s Republic of China.  2Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, People\u2019s Republic of China.","username":null,"profile_image":null},{"name":" Xiwen Zhang1","affiliation":"1Department of Cardiology, Huai\u2019an First People\u2019s Hospital, Nanjing Medical University, Huai\u2019an, Jiangsu, People\u2019s Republic of China.  2Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, People\u2019s Republic of China.","username":null,"profile_image":null},{"name":" Xiaoyi Tian1","affiliation":"1Department of Cardiology, Huai\u2019an First People\u2019s Hospital, Nanjing Medical University, Huai\u2019an, Jiangsu, People\u2019s Republic of China.  2Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, People\u2019s Republic of China.","username":null,"profile_image":null},{"name":" Shuren Ma1","affiliation":"1Department of Cardiology, Huai\u2019an First People\u2019s Hospital, Nanjing Medical University, Huai\u2019an, Jiangsu, People\u2019s Republic of China.  2Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, People\u2019s Republic of China.","username":null,"profile_image":null}],"user":{"profile_image":"\/img\/avatars\/007.png","username":"xiaoxuan-gong","full_name":"Xiaoxuan Gong","created_by":"Xiaoxuan Gong"},"access":{"can_view":"1","can_remove":"0","can_add":"0","can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":"0","can_move":"1","can_transfer":"1","can_download":"1","is_locked":"0"},"is_contact_suspended":0,"guidelines":null,"status_id":"1","is_research":"1","status_info":null,"steps":[{"id":"575073","is_changed":"0","original_id":"574985","is_skipped":"0","is_checked":"0","guid":"F98664C1DD3C44F8A2201FD7028EC0C0","previous_guid":"6300C7D836E64343947E491BE46F0ACA","previous_id":"575074","last_modified":"1497883772","components":[{"component_id":"951260","previous_id":0,"original_id":"951063","guid":"667927AC11A14AE18D559353EFFBBD15","previous_guid":null,"component_type_id":"1","data_id":null,"data":"<p>Search databases: PubMed, Embase and Cochrane Central\u00a0<\/p>\n<p>Search key words:\u00a0(\u201catrial fibrillation\u201d or \u201cAF\u201d) and (\u201cpercutaneous coronary intervention\u201d or \u201cPCI\u201d or \u201ccoronary stent implantation\u201d) and (\u201caspirin\u201d or \u201cP2Y<sub>12<\/sub> antagonist\u201d or\u00a0 \u201cP2Y<sub>12<\/sub> inhibitor\u201d or \u201cclopidogrel\u201d or \u201cticagrelor\u201d or \u201cwarfarin\u201d or \u201cvitamin K antagonist\u201d or \u201cVKA\u201d or \u201cdabigatran\u201d or \u201crivaroxaban\u201d or \u201capixaban\u201d or \u201cedoxaban\u201d or \u201cnovel oral anticoagulant\u201d or \u201cnew oral anticoagulant\u201d or \u201cNOAC\u201d)<\/p>\n<p>Two reviewers search key words independently from the earliest possible search date till March 2017.<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>Search databases: PubMed, Embase and Cochrane Central\u00a0<\/p>\n<p>Search key words:\u00a0(\u201catrial fibrillation\u201d or \u201cAF\u201d) and (\u201cpercutaneous coronary intervention\u201d or \u201cPCI\u201d or \u201ccoronary stent implantation\u201d) and (\u201caspirin\u201d or \u201cP2Y<sub>12<\/sub> antagonist\u201d or\u00a0 \u201cP2Y<sub>12<\/sub> inhibitor\u201d or \u201cclopidogrel\u201d or \u201cticagrelor\u201d or \u201cwarfarin\u201d or \u201cvitamin K antagonist\u201d or \u201cVKA\u201d or \u201cdabigatran\u201d or \u201crivaroxaban\u201d or \u201capixaban\u201d or \u201cedoxaban\u201d or \u201cnovel oral anticoagulant\u201d or \u201cnew oral anticoagulant\u201d or \u201cNOAC\u201d)<\/p>\n<p>Two reviewers search key words independently from the earliest possible search date till March 2017.<\/p>"},"is_project":0},{"component_id":"951261","previous_id":"951260","original_id":"951064","guid":"50045A1EB6AF40C08FBDC91FED415CD8","previous_guid":"667927AC11A14AE18D559353EFFBBD15","component_type_id":"6","data_id":null,"data":"Identify all possible records through databases","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Identify all possible records through databases"},"is_project":0}]},{"id":"575074","is_changed":"0","original_id":"574994","is_skipped":"0","is_checked":"0","guid":"6300C7D836E64343947E491BE46F0ACA","previous_guid":null,"previous_id":"0","last_modified":"1497885211","components":[{"component_id":"951262","previous_id":0,"original_id":"951081","guid":"3C608DC1035943C9B9A91129DF0ED6A8","previous_guid":null,"component_type_id":"1","data_id":null,"data":"<p style=\"text-align: left;\">Inclusion criteria:<\/p>\n<p style=\"text-align: left;\">(1) clinical trials with at least one compared group;<\/p>\n<p style=\"text-align: left;\">(2) study population of coronary artery disease\u00a0patients with paroxysmal, persistent, or permanent AF undergoing PCI;<\/p>\n<p style=\"text-align: left;\">(3) treatment with antiplatelet drugs\u00a0(aspirin\u00a0and\u00a0P2Y12 inhibitors) and\/or anticoagulants (warfarin\u00a0and\u00a0new oral anticoagulants such as\u00a0dabigatran,\u00a0rivaroxaban,\u00a0apixaban\u00a0and\u00a0edoxaban)\u00a0with a target international normalized ratio (INR) of 2.0-3.0 if\u00a0warfarin is\u00a0used to reflect present standard practice;<\/p>\n<p style=\"text-align: left;\">(4) outcomes involving main adverse cardiac and cerebrovascular events (MACCEs) and major bleeding;<\/p>\n<p style=\"text-align: left;\">(5) mean or median follow-up period no less than 12 months.<\/p>\n<p style=\"text-align: left;\">Exclusion criteria:\u00a0<\/p>\n<p style=\"text-align: left;\">(1) articles\u00a0published only in the form of abstracts or in non-English languages;<\/p>\n<p style=\"text-align: left;\">(2) antithrombotic therapies change differently in post-PCI;<\/p>\n<p style=\"text-align: left;\">(3) vague\u00a0compared treatments such as VKA <em>vs.<\/em> non-VAK.<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p style=\"text-align: left;\">Inclusion criteria:<\/p>\n<p style=\"text-align: left;\">(1) clinical trials with at least one compared group;<\/p>\n<p style=\"text-align: left;\">(2) study population of coronary artery disease\u00a0patients with paroxysmal, persistent, or permanent AF undergoing PCI;<\/p>\n<p style=\"text-align: left;\">(3) treatment with antiplatelet drugs\u00a0(aspirin\u00a0and\u00a0P2Y12 inhibitors) and\/or anticoagulants (warfarin\u00a0and\u00a0new oral anticoagulants such as\u00a0dabigatran,\u00a0rivaroxaban,\u00a0apixaban\u00a0and\u00a0edoxaban)\u00a0with a target international normalized ratio (INR) of 2.0-3.0 if\u00a0warfarin is\u00a0used to reflect present standard practice;<\/p>\n<p style=\"text-align: left;\">(4) outcomes involving main adverse cardiac and cerebrovascular events (MACCEs) and major bleeding;<\/p>\n<p style=\"text-align: left;\">(5) mean or median follow-up period no less than 12 months.<\/p>\n<p style=\"text-align: left;\">Exclusion criteria:\u00a0<\/p>\n<p style=\"text-align: left;\">(1) articles\u00a0published only in the form of abstracts or in non-English languages;<\/p>\n<p style=\"text-align: left;\">(2) antithrombotic therapies change differently in post-PCI;<\/p>\n<p style=\"text-align: left;\">(3) vague\u00a0compared treatments such as VKA <em>vs.<\/em> non-VAK.<\/p>"},"is_project":0},{"component_id":"951263","previous_id":"951262","original_id":"951082","guid":"0FEC80238B90491080A6BAF5EDE420E3","previous_guid":"3C608DC1035943C9B9A91129DF0ED6A8","component_type_id":"6","data_id":null,"data":"Inclusion and exclusion criteria","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Inclusion and exclusion criteria"},"is_project":0}]},{"id":"575075","is_changed":"0","original_id":"574995","is_skipped":"0","is_checked":"0","guid":"7C812721BE14451F8910CDFFD5004205","previous_guid":"8B6A050C0E3D4329938986B3FEEE1C52","previous_id":"575080","last_modified":"1497884260","components":[{"component_id":"951264","previous_id":0,"original_id":"951083","guid":"CB0417C35559422094F716FC5843E57C","previous_guid":null,"component_type_id":"1","data_id":null,"data":"","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":""},"is_project":0},{"component_id":"951265","previous_id":"951264","original_id":"951084","guid":"25BA167BC735427C83AF458F13EADC22","previous_guid":"CB0417C35559422094F716FC5843E57C","component_type_id":"6","data_id":null,"data":"Exclude irrelevant studies and non-English language articles based on titles and abstracts.","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Exclude irrelevant studies and non-English language articles based on titles and abstracts."},"is_project":0}]},{"id":"575076","is_changed":"0","original_id":"574996","is_skipped":"0","is_checked":"0","guid":"B77311C6FFC24B938899016BFF3CE831","previous_guid":"7C812721BE14451F8910CDFFD5004205","previous_id":"575075","last_modified":"1497884505","components":[{"component_id":"951266","previous_id":0,"original_id":"951085","guid":"8E56C930B8A3479FA3406BEA6541842B","previous_guid":null,"component_type_id":"1","data_id":null,"data":"<p>Remove unqualified studies\u00a0after assessment of full-text studies:<\/p>\n<p>(1) article type: clinical trial designs, reviews, meta analyses, letters, case reports, comments, editorials, survey and investigation;<\/p>\n<p>(2) without at least a control group or non-AF patients underwent PCI included;<\/p>\n<p>(3) obviously changed treatments in peri-PCI;<\/p>\n<p>(4) without MACCEs or major bleeding endpoints;<\/p>\n<p>(5) mean\/median follow-up periods less than 1 year.<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>Remove unqualified studies\u00a0after assessment of full-text studies:<\/p>\n<p>(1) article type: clinical trial designs, reviews, meta analyses, letters, case reports, comments, editorials, survey and investigation;<\/p>\n<p>(2) without at least a control group or non-AF patients underwent PCI included;<\/p>\n<p>(3) obviously changed treatments in peri-PCI;<\/p>\n<p>(4) without MACCEs or major bleeding endpoints;<\/p>\n<p>(5) mean\/median follow-up periods less than 1 year.<\/p>"},"is_project":0},{"component_id":"951267","previous_id":"951266","original_id":"951086","guid":"B8537E029C8D46B5B950C62F0AD78698","previous_guid":"8E56C930B8A3479FA3406BEA6541842B","component_type_id":"6","data_id":null,"data":"Get all qualified studies included in this network meta-analysis after full-text assessment.","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Get all qualified studies included in this network meta-analysis after full-text assessment."},"is_project":0}]},{"id":"575077","is_changed":"0","original_id":"575001","is_skipped":"0","is_checked":"0","guid":"295A2856549D4FF6860533CA92549552","previous_guid":"B77311C6FFC24B938899016BFF3CE831","previous_id":"575076","last_modified":"1497884797","components":[{"component_id":"951268","previous_id":0,"original_id":"951096","guid":"FAB65A51ED75434FB2865C167FDA3E0C","previous_guid":null,"component_type_id":"1","data_id":null,"data":"<p>Collected data: study design, sample size (all and in compared arms), follow-up duration, antithrombotic strategies in post-PCI, efficacy and safety outcomes, baseline characteristics of the patients including mean age, male percentage, mean CHADS<sub>2<\/sub>\/CHA<sub>2<\/sub>DS<sub>2<\/sub>-VASc and HAS-BLED scores, the number and percentage of MACCEs (including all-cause mortality, cardiac death, myocardial infarction, target lesion revascularization and stroke) as primary outcome and major bleeding outcomes (defined by TIMI or the Bleeding Academic Research Consortium [BARC] criteria) as secondary outcome both in around 1-year follow-up in every arm.<\/p>\n<p>\u00a0<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>Collected data: study design, sample size (all and in compared arms), follow-up duration, antithrombotic strategies in post-PCI, efficacy and safety outcomes, baseline characteristics of the patients including mean age, male percentage, mean CHADS<sub>2<\/sub>\/CHA<sub>2<\/sub>DS<sub>2<\/sub>-VASc and HAS-BLED scores, the number and percentage of MACCEs (including all-cause mortality, cardiac death, myocardial infarction, target lesion revascularization and stroke) as primary outcome and major bleeding outcomes (defined by TIMI or the Bleeding Academic Research Consortium [BARC] criteria) as secondary outcome both in around 1-year follow-up in every arm.<\/p>\n<p>\u00a0<\/p>"},"is_project":0},{"component_id":"951269","previous_id":"951268","original_id":"951097","guid":"43B8A0E9C34C42E2889D565219D4499F","previous_guid":"FAB65A51ED75434FB2865C167FDA3E0C","component_type_id":"6","data_id":null,"data":"Data extraction","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Data extraction"},"is_project":0}]},{"id":"575078","is_changed":"0","original_id":"575010","is_skipped":"0","is_checked":"0","guid":"32045E3933754E16802FB6CDDE7782CE","previous_guid":"295A2856549D4FF6860533CA92549552","previous_id":"575077","last_modified":"1497884892","components":[{"component_id":"951270","previous_id":0,"original_id":"951115","guid":"BC6DA73BA1194FEBAB574E44CFC7CC80","previous_guid":null,"component_type_id":"1","data_id":null,"data":"<p>Assess the qualities of observational studies by the Newcastle-Ottawa Scale (NOS, evaluation of selection, comparability and outcome) and randomized controlled trials (RCTs)\u00a0by Jadad Scale (judgment of randomization, double\u00a0blind, withdrawals\u00a0and dropouts) respectively.<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>Assess the qualities of observational studies by the Newcastle-Ottawa Scale (NOS, evaluation of selection, comparability and outcome) and randomized controlled trials (RCTs)\u00a0by Jadad Scale (judgment of randomization, double\u00a0blind, withdrawals\u00a0and dropouts) respectively.<\/p>"},"is_project":0},{"component_id":"951271","previous_id":"951270","original_id":"951116","guid":"7919F16914CC4F8FB1C006A8A3A179DC","previous_guid":"BC6DA73BA1194FEBAB574E44CFC7CC80","component_type_id":"6","data_id":null,"data":"Quality assessment","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Quality assessment"},"is_project":0}]},{"id":"575079","is_changed":"0","original_id":"575014","is_skipped":"0","is_checked":"0","guid":"9FF14D1C9E394399B8BFAC3B584D84BC","previous_guid":"32045E3933754E16802FB6CDDE7782CE","previous_id":"575078","last_modified":"1497885622","components":[{"component_id":"951272","previous_id":0,"original_id":"951124","guid":"5C2236A8255748EEA7A271FD353DEA6F","previous_guid":null,"component_type_id":"1","data_id":null,"data":"<p>Treat results for endpoint events as dichotomous data. Use risk ratio (RR) and 95% confidence interval (CI) to estimate pooled results from studies. Conduct a Bayesian network meta-analysis\u00a0in Addis 1.16.8 software by Markov chain Monte Carlo methods, which provides direct and indirect evidence for any given treatments in one joint analysis and a possible ranking distribution of 2 endpoints for all regimens<em>.<\/em> If 95% CI of inconsistency factors median contains 0 and <em>p<\/em> value of node split model is\u00a0over 0.05, inconsistent model will be considered not significant. Then use consistent model for further analysis.<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>Treat results for endpoint events as dichotomous data. Use risk ratio (RR) and 95% confidence interval (CI) to estimate pooled results from studies. Conduct a Bayesian network meta-analysis\u00a0in Addis 1.16.8 software by Markov chain Monte Carlo methods, which provides direct and indirect evidence for any given treatments in one joint analysis and a possible ranking distribution of 2 endpoints for all regimens<em>.<\/em> If 95% CI of inconsistency factors median contains 0 and <em>p<\/em> value of node split model is\u00a0over 0.05, inconsistent model will be considered not significant. Then use consistent model for further analysis.<\/p>"},"is_project":0},{"component_id":"951273","previous_id":"951272","original_id":"951125","guid":"C676E81BE0CB4A59BC2BA8689E5412D5","previous_guid":"5C2236A8255748EEA7A271FD353DEA6F","component_type_id":"6","data_id":null,"data":"Statistical analysis","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Statistical analysis"},"is_project":0}]},{"id":"575080","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"8B6A050C0E3D4329938986B3FEEE1C52","previous_guid":"F98664C1DD3C44F8A2201FD7028EC0C0","previous_id":"575073","last_modified":"1497884069","components":[{"component_id":"951274","previous_id":0,"original_id":"0","guid":"60FA7A5B8A6048178A2D5D63E35117D0","previous_guid":null,"component_type_id":"1","data_id":null,"data":"","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":""},"is_project":0},{"component_id":"951275","previous_id":"951274","original_id":"0","guid":"D147E1EF49D44A05A6845B13F6A31490","previous_guid":"60FA7A5B8A6048178A2D5D63E35117D0","component_type_id":"6","data_id":null,"data":"Remove duplicate records by titles and abstracts.","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Remove duplicate records by titles and abstracts."},"is_project":0}]}]}